{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:56:01Z","timestamp":1793314561502,"version":"4.5.0"},"reference-count":126,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Spinal cord injury (SCI) causes irreversible neurological deficits and represents a major global health and socioeconomic burden. Although neural progenitor cell (NPC) transplantation is strongly supported by preclinical evidence through cell replacement, intrinsic neuroregeneration, and broad neurotrophic and immunomodulatory effects, its clinical translation has progressed more slowly than anticipated. In parallel, rapid advances in gene editing, biomaterial engineering, and organoid technologies are reshaping the therapeutic landscape. Therefore, it is timely to systematically re-evaluate the current evidence on NPC-based therapies for SCI and to refine future translational strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>This review provides an updated and comprehensive overview of NPC therapy for SCI across the full translational continuum. First, we summarize the biological properties, advantages, and limitations of NPCs derived from adult or embryonic neural tissues, embryonic stem cells (ESCs), and induced pluripotent stem cells (iPSCs), highlighting issues such as tumorigenicity, immune responses, and manufacturing standardization. We then focus on efficacy-oriented genetic modifications and engineered delivery systems, including NPCs overexpressing neurotrophic, synaptogenic, or pro-survival factors, as well as combination strategies integrating NPCs with biomaterials, small molecules, or immunomodulatory agents to enhance graft survival, circuit reconstruction, and motor and sensory recovery. Subsequently, we systematically analyze 19 clinical trials of NPC\/NSC-based products conducted in 10 countries, covering HuCNS-SC, LCTOPC1, NSI-566, hESC-OPC, and the emerging iPSC-derived product XS228. Trial designs, dosing regimens, routes of administration, safety profiles, and preliminary functional outcomes are compared, and key design principles for next-generation clinical trials and patient selection are proposed. Finally, we discuss organoid-based approaches and artificial intelligence (AI)\u2013assisted decision tools as emerging platforms for disease modeling, protocol optimization, and precision indication refinement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      NPC-based therapy for SCI remains at an early but promising translational stage. No NPC product has yet achieved regulatory approval, reflecting persistent challenges in cell source optimization, safety control, graft survival,\n                      <jats:italic>in vivo<\/jats:italic>\n                      tracking, and trial design. Nevertheless, by integrating rigorous cell source selection, rational gene modification, advanced delivery systems, and well-designed clinical trials targeting carefully defined patient populations, NPCs are expected to achieve meaningful\u2014and potentially transformative\u2014clinical benefits for individuals with SCI in the future.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1772547","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:36:23Z","timestamp":1779683783000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Current status of neural progenitor\/stem cells for spinal cord injury: fundamental research and clinical trials"],"prefix":"10.3389","volume":"17","author":[{"given":"Xin-xin","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Burns, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Burns, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-hang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Burns, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences","place":["Beijing, China"]},{"name":"National Stem Cell Resource Center, Institute of Zoology, Chinese Academy of Sciences","place":["Beijing, China"]},{"name":"Institute for Stem Cell and Regenerative Medicine, Chinese Academy of Sciences","place":["Beijing, China"]},{"name":"Beijing Institute for Stem Cell and Regenerative Medicine","place":["Beijing, China"]},{"name":"University of Chinese Academy of Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhou","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences","place":["Beijing, China"]},{"name":"National Stem Cell Resource Center, Institute of Zoology, Chinese Academy of Sciences","place":["Beijing, China"]},{"name":"Institute for Stem Cell and Regenerative Medicine, Chinese Academy of Sciences","place":["Beijing, China"]},{"name":"Beijing Institute for Stem Cell and Regenerative Medicine","place":["Beijing, China"]},{"name":"University of Chinese Academy of Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-ao","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Burns, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences","place":["Beijing, China"]},{"name":"National Stem Cell Resource Center, Institute of Zoology, Chinese Academy of Sciences","place":["Beijing, China"]},{"name":"Institute for Stem Cell and Regenerative Medicine, Chinese Academy of Sciences","place":["Beijing, China"]},{"name":"Beijing Institute for Stem Cell and Regenerative Medicine","place":["Beijing, China"]},{"name":"University of Chinese Academy of Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000336014","article-title":"Incidence and prevalence of spinal cord injury in Canada: a national perspective","volume":"38","author":"Noonan","year":"2012","journal-title":"Neuroepidemiology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/sj.sc.3101616","article-title":"Prevalence of spinal cord injury in Helsinki","volume":"43","author":"Dahlberg","year":"2005","journal-title":"Spinal Cord"},{"key":"B3","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fneur.2019.00282","article-title":"Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms","volume":"10","author":"Alizadeh","year":"2019","journal-title":"Front Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.55782\/ane-2011-1848","article-title":"Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade","volume":"71","author":"Oyinbo","year":"2011","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41583-020-0314-2","article-title":"Transplanting neural progenitor cells to restore connectivity after spinal cord injury","volume":"21","author":"Fischer","year":"2020","journal-title":"Nat Rev Neurosci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e12021","DOI":"10.1371\/journal.pone.0012021","article-title":"Spatio-temporal progression of grey and white matter damage following contusion injury in rat spinal cord","volume":"5","author":"Ek","year":"2010","journal-title":"PLoS ONE"},{"key":"B7","doi-asserted-by":"publisher","first-page":"119230","DOI":"10.1016\/j.biomaterials.2019.119230","article-title":"Different functional bio-scaffolds share similar neurological mechanism to promote locomotor recovery of canines with complete spinal cord injury","volume":"214","author":"Liu","year":"2019","journal-title":"Biomaterials"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5073","DOI":"10.1016\/j.ymthe.2025.07.041","article-title":"Fetal rat neural progenitor cell transplantation after spinal cord injury improves motor recovery following optogenetic stimulation","volume":"33","author":"S\u00e1nchez-Mart\u00edn","year":"2025","journal-title":"Mol Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/aps.2012.107","article-title":"Role of neural precursor cells in promoting repair following stroke","volume":"34","author":"Dibajnia","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"B10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2184.2008.00486.x","article-title":"Stem cells and neurological diseases","volume":"41","author":"Hess","year":"2008","journal-title":"Cell Prolif"},{"key":"B11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.conb.2004.01.008","article-title":"Disguising adult neural stem cells","volume":"14","author":"Morshead","year":"2004","journal-title":"Curr Opin Neurobiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1089\/neu.2009.1177","article-title":"A systematic review of cellular transplantation therapies for spinal cord injury","volume":"28","author":"Tetzlaff","year":"2011","journal-title":"J Neurotrauma"},{"key":"B13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0014-4886(03)00037-2","article-title":"Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury","volume":"181","author":"Lu","year":"2003","journal-title":"Exp Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/scrt219","article-title":"Human conditionally immortalized neural stem cells improve locomotor function after spinal cord injury in the rat","volume":"4","author":"Amemori","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"B15","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.stemcr.2019.03.013","article-title":"Adult neural progenitor cells transplanted into spinal cord injury differentiate into oligodendrocytes, enhance myelination, and contribute to recovery","volume":"12","author":"Sankavaram","year":"2019","journal-title":"Stem Cell Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00018-022-04494-w","article-title":"NPC transplantation rescues sci-driven cAMP\/EPAC2 alterations, leading to neuroprotection and microglial modulation","volume":"79","author":"Mart\u00ednez-Rojas","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.cell.2012.08.020","article-title":"Long-distance growth and connectivity of neural stem cells after severe spinal cord injury","volume":"150","author":"Lu","year":"2012","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"574","DOI":"10.2174\/157015911798376299","article-title":"Functional multipotency of stem cells: a conceptual review of neurotrophic factor-based evidence and its role in translational research","volume":"9","author":"Teng","year":"2011","journal-title":"Curr Neuropharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e13319","DOI":"10.1111\/cpr.13319","article-title":"Inducible motor neuron differentiation of human induced pluripotent stem cells in vivo","volume":"55","author":"Chen","year":"2022","journal-title":"Cell Prolif"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.cell.2023.02.017","article-title":"Purification and characterization of human neural stem and progenitor cells","volume":"186","author":"Liu","year":"2023","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0076-6879(06)19001-1","article-title":"Neural stem cell isolation and characterization","volume":"419","author":"Rietze","year":"2006","journal-title":"Methods Enzymol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.conb.2020.10.014","article-title":"Fate restrictions in embryonic neural progenitors","volume":"66","author":"Fischer","year":"2021","journal-title":"Curr Opin Neurobiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat Biotechnol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2174\/1574888X14666190823142911","article-title":"Human pluripotent stem cells in neurodegenerative diseases: potentials, advances and limitations","volume":"15","author":"Kolagar","year":"2020","journal-title":"Curr Stem Cell Res Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.13004\/kjnt.2025.21.e36","article-title":"Intramedullary neural stem cell transplantation in spinal cord injury: timing, targets, and techniques","volume":"21","author":"Kwon","year":"2025","journal-title":"Korean J Neurotrauma"},{"key":"B27","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1227\/NEU.0000000000000882","article-title":"Preclinical validation of multilevel intraparenchymal stem cell therapy in the porcine spinal cord","volume":"77","author":"Gutierrez","year":"2015","journal-title":"Neurosurgery"},{"key":"B28","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.stem.2018.05.014","article-title":"A first-in-human, phase I study of neural stem cell transplantation for chronic spinal cord injury","volume":"22","author":"Curtis","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1227\/NEU.0b013e31825ca05f","article-title":"Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes","volume":"71","author":"Riley","year":"2012","journal-title":"Neurosurgery"},{"key":"B30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/neuros\/nyx242","article-title":"Human neural stem cell transplantation in chronic cervical spinal cord injury: functional outcomes at 12 months in a phase II clinical trial","volume":"64","author":"Ghobrial","year":"2017","journal-title":"Neurosurgery"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1089\/scd.2011.0596","article-title":"An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury","volume":"21","author":"Hawryluk","year":"2012","journal-title":"Stem Cells Dev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"9807978","DOI":"10.1155\/2019\/9807978","article-title":"High-dose neural stem\/progenitor cell transplantation increases engraftment and neuronal distribution and promotes functional recovery in rats after acutely severe spinal cord injury","volume":"2019","author":"Yuan","year":"2019","journal-title":"Stem Cells Int"},{"key":"B33","doi-asserted-by":"publisher","first-page":"119941","DOI":"10.1016\/j.biomaterials.2020.119941","article-title":"A functional scaffold to promote the migration and neuronal differentiation of neural stem\/progenitor cells for spinal cord injury repair","volume":"243","author":"Liu","year":"2020","journal-title":"Biomaterials"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e21744","DOI":"10.1371\/journal.pone.0021744","article-title":"Effects of dibutyryl cyclic-AMP on survival and neuronal differentiation of neural stem\/progenitor cells transplanted into spinal cord injured rats","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS ONE"},{"key":"B35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/ph12020065","article-title":"Filling the gap: neural stem cells as a promising therapy for spinal cord injury","volume":"12","author":"Pereira","year":"2019","journal-title":"Pharmaceuticals"},{"key":"B36","doi-asserted-by":"publisher","first-page":"104207","DOI":"10.1016\/j.bas.2025.104207","article-title":"Stem cell therapies for spinal cord injury in humans: a review of recent clinical research","volume":"5","author":"Sugai","year":"2025","journal-title":"Brain Spine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nm.4502","article-title":"Restorative effects of human neural stem cell grafts on the primate spinal cord","volume":"24","author":"Rosenzweig","year":"2018","journal-title":"Nat Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.reth.2021.08.005","article-title":"First-in-human clinical trial of transplantation of iPSC-derived NS\/PCs in subacute complete spinal cord injury: study protocol","volume":"18","author":"Sugai","year":"2021","journal-title":"Regen Ther"},{"key":"B39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s41232-020-00149-0","article-title":"Regenerative therapy for spinal cord injury using iPSC technology","volume":"40","author":"Nagoshi","year":"2020","journal-title":"Inflamm Regen"},{"key":"B40","doi-asserted-by":"publisher","first-page":"eaau3538","DOI":"10.1126\/scitranslmed.aau3538","article-title":"GDNF rescues the fate of neural progenitor grafts by attenuating Notch signals in the injured spinal cord in rodents","volume":"12","author":"Khazaei","year":"2020","journal-title":"Sci Transl Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4771522","article-title":"Association between neural stem\/progenitor cells and biomaterials in spinal cord injury therapies: a systematic review and network meta-analysis","author":"Jeon","year":"2024","journal-title":"Acta Biomater"},{"key":"B42","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.1097\/j.pain.0000000000003306","article-title":"Regenerative medicine for spinal cord injury using induced pluripotent stem cells: from animals to humans","volume":"165","author":"Nagoshi","year":"2024","journal-title":"Pain"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e158000","DOI":"10.1172\/jci.insight.158000","article-title":"Rehabilitation combined with neural progenitor cell grafts enables functional recovery in chronic spinal cord injury","volume":"7","author":"Lu","year":"2022","journal-title":"JCI Insight"},{"key":"B44","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13287-024-03770-9","article-title":"Combination of induced pluripotent stem cell-derived motor neuron progenitor cells with irradiated brain-derived neurotrophic factor over-expressing engineered mesenchymal stem cells enhanced restoration of axonal regeneration in a chronic spinal cord injury rat model","volume":"15","author":"Kim","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"B45","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1080\/00016480802468153","article-title":"Transplantation of neural stem cells overexpressing glia-derived neurotrophic factor promotes facial nerve regeneration","volume":"129","author":"Shi","year":"2009","journal-title":"Acta Otolaryngol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3969\/j.issn.1673-4254.2016.01.06","article-title":"Therapeutic effect of GDNF gene-modified mesencephalic neural stem cell transplantation in a rat model of Parkinson disease","volume":"36","author":"Duan","year":"2016","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"B47","doi-asserted-by":"publisher","first-page":"679","DOI":"10.5607\/en.2019.28.6.679","article-title":"Glial cell line-derived neurotrophic factor-overexpressing human neural stem\/progenitor cells enhance therapeutic efficiency in rat with traumatic spinal cord injury","volume":"28","author":"Hwang","year":"2019","journal-title":"Exp Neurobiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.7507\/1002-1892.201710079","article-title":"Influence of Nogo extracellular peptide residues 1-40 gene modification on survival and differentiation of neural stem cells after transplantation","volume":"27","author":"Wang","year":"2013","journal-title":"Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi"},{"key":"B49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41586-018-0467-6","article-title":"Required growth facilitators propel axon regeneration across complete spinal cord injury","volume":"561","author":"Anderson","year":"2018","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10571-016-0448-y","article-title":"Exogenous expression of Nt-3 and TrkC genes in bone marrow stromal cells elevated the survival rate of the cells in the course of neural differentiation","volume":"37","author":"Edalat","year":"2017","journal-title":"Cell Mol Neurobiol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.brainresbull.2008.02.037","article-title":"Retrovirus delivered neurotrophin-3 promotes survival, proliferation and neuronal differentiation of human fetal neural stem cells in vitro","volume":"77","author":"Lu","year":"2008","journal-title":"Brain Res Bull"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1016\/j.bioactmat.2021.03.036","article-title":"TrkCAn NT-3-releasing bioscaffold supports the formation of TrkC-modified neural stem cell-derived neural network tissue with efficacy in repairing spinal cord injury","volume":"6","author":"Li","year":"2021","journal-title":"Bioact Mater"},{"key":"B53","doi-asserted-by":"publisher","first-page":"8744","DOI":"10.3390\/ijms25168744","article-title":"Effects of human neural stem cells overexpressing neuroligin and neurexin in a spinal cord injury model","volume":"25","author":"Jeong","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.stemcr.2024.01.007","article-title":"Human-induced pluripotent stem cell-derived neural stem\/progenitor cell ex vivo gene therapy with synaptic organizer CPTX for spinal cord injury","volume":"19","author":"Saijo","year":"2024","journal-title":"Stem Cell Rep"},{"key":"B55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijdevneu.2011.12.006","article-title":"Induction of neural differentiation by the transcription factor neuroD2","volume":"30","author":"Messmer","year":"2012","journal-title":"Int J Dev Neurosci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41536-021-00179-3","article-title":"Analysis of the early response to spinal cord injury identified a key role for mTORC1 signaling in the activation of neural stem progenitor cells","volume":"6","author":"Pe\u00f1ailillo","year":"2021","journal-title":"NPJ Regen Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1016\/j.stemcr.2021.09.006","article-title":"LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS\/PC transplantation for contusive spinal cord injury","volume":"16","author":"Ito","year":"2021","journal-title":"Stem Cell Rep"},{"key":"B58","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1007\/s11064-020-03210-z","article-title":"Unlocking the recovery potential: JMJD3 inhibition-mediated SAPK\/JNK signaling inactivation supports endogenous oligodendrocyte-lineage commitment post mammalian spinal cord injury","volume":"46","author":"Bo-Yin","year":"2021","journal-title":"Neurochem Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1096\/fj.201901478RR","article-title":"Wnt4-modified NSC transplantation promotes functional recovery after spinal cord injury","volume":"34","author":"Li","year":"2020","journal-title":"FASEB J"},{"key":"B60","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/BRS.0000000000004264","article-title":"Pharmacologic recruitment of endogenous neural stem\/progenitor cells for the treatment of spinal cord injury","volume":"47","author":"Zabarsky","year":"2022","journal-title":"Spine (Phila Pa 1976)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e0436","DOI":"10.1097\/CCE.0000000000000436","article-title":"Induction of neurogenesis and angiogenesis in a rat hemisection spinal cord injury model with combined neural stem cell, endothelial progenitor cell, and biomimetic hydrogel matrix therapy","volume":"3","author":"Marrotte","year":"2021","journal-title":"Crit Care Explor"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/jnr.22322","article-title":"Transplantation of galectin-1-expressing human neural stem cells into the injured spinal cord of adult common marmosets","volume":"88","author":"Yamane","year":"2010","journal-title":"J Neurosci Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e2105694","DOI":"10.1002\/advs.202105694","article-title":"Regenerating the injured spinal cord at the chronic phase by engineered iPSCs-derived 3D neuronal networks","volume":"9","author":"Wertheim","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B64","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3727\/096020198389942","article-title":"TrkC overexpression enhances survival and migration of neural stem cell transplants in the rat spinal cord","volume":"11","author":"Castellanos","year":"2002","journal-title":"Cell Transpl"},{"key":"B65","first-page":"156","article-title":"HuCNS-SC (StemCells)","volume":"8","author":"Taupin","year":"2006","journal-title":"Curr Opin Mol Ther"},{"key":"B66","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1089\/neu.2018.5843","article-title":"Clinical outcomes from a multi-center study of human neural stem cell transplantation in chronic cervical spinal cord injury","volume":"36","author":"Levi","year":"2019","journal-title":"J Neurotrauma"},{"key":"B67","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3171\/2022.5.SPINE22167","article-title":"A phase 1\/2a dose-escalation study of oligodendrocyte progenitor cells in individuals with subacute cervical spinal cord injury","volume":"37","author":"Fessler","year":"2022","journal-title":"J Neurosurg Spine"},{"key":"B68","doi-asserted-by":"publisher","first-page":"630932","DOI":"10.1155\/2015\/630932","article-title":"Clinical trial of human fetal brain-derived neural stem\/progenitor cell transplantation in patients with traumatic cervical spinal cord injury","volume":"2015","author":"Shin","year":"2015","journal-title":"Neural Plast"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.5966\/sctm.2014-0147","article-title":"Wrongful termination: lessons from the Geron clinical trial","volume":"3","author":"Scott","year":"2014","journal-title":"Stem Cells Transl Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/SCCAA.S28477","article-title":"Potential role of stem cells in severe spinal cord injury: current perspectives and clinical data","volume":"5","author":"Paspala","year":"2012","journal-title":"Stem Cells Cloning"},{"key":"B71","doi-asserted-by":"publisher","first-page":"8540","DOI":"10.3390\/ijms25158540","article-title":"Therapeutic transplantation of human central nervous system organoids for neural reconstruction","volume":"25","author":"Hong","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e2406742","DOI":"10.1002\/advs.202406742","article-title":"Regulating astrocytes via short fibers for spinal cord repair","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e38001","DOI":"10.1002\/jbm.a.38001","article-title":"GelMA hydrogel encapsulating iPSC-derived human spinal cord organoids enhances neural regeneration and restores motor function in rat spinal cord injury","volume":"113","author":"Li","year":"2025","journal-title":"J Biomed Mater Res A"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.5846\/stxb202011303055","article-title":"Study of coastal zone ecosystem restoration in the context of carbon storage change: a case of Dongying City","author":"Sui","year":"2021","journal-title":"Acta Ecol Sin"},{"key":"B75","doi-asserted-by":"publisher","first-page":"9832128","DOI":"10.34133\/2022\/9832128","article-title":"CNS organoid surpasses cell-laden microgel assembly to promote spinal cord injury repair","volume":"2022","author":"Wang","year":"2022","journal-title":"Research (Wash D C)"},{"key":"B76","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.3390\/ijms23105788","article-title":"Towards 3D bioprinted spinal cord organoids","volume":"23","author":"Han","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B77","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41551-022-00963-6","article-title":"Generation of neural organoids for spinal-cord regeneration via the direct reprogramming of human astrocytes","volume":"7","author":"Xu","year":"2023","journal-title":"Nat Biomed Eng"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1093\/brain\/awad047","article-title":"Cell therapies for spinal cord injury: a review of the clinical trials and cell-type therapeutic potential","volume":"146","author":"Ribeiro","year":"2023","journal-title":"Brain"},{"key":"B79","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/brain\/awad392","article-title":"Neural stem cell therapies for spinal cord injury repair: an update on recent preclinical and clinical advances","volume":"147","author":"Hosseini","year":"2024","journal-title":"Brain"},{"key":"B80","doi-asserted-by":"publisher","first-page":"114267","DOI":"10.1016\/j.expneurol.2022.114267","article-title":"Porcine spinal cord injury model for translational research across multiple functional systems","volume":"359","author":"Ahmed","year":"2023","journal-title":"Exp Neurol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/sc.2016.187","article-title":"Animal models of spinal cord injury: a systematic review","volume":"55","author":"Sharif-Alhoseini","year":"2017","journal-title":"Spinal Cord"},{"key":"B82","doi-asserted-by":"publisher","first-page":"10423","DOI":"10.1038\/s41467-025-65395-7","article-title":"Functional synaptic connectivity of engrafted spinal cord neurons with hindlimb motor circuitry in the injured spinal cord","volume":"16","author":"Tucker","year":"2025","journal-title":"Nat Commun"},{"key":"B83","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1523\/JNEUROSCI.0362-25.2025","article-title":"Circuit reconstruction after traumatic spinal cord injury by cellular and pharmacological approaches","author":"Hosseini","year":"2025","journal-title":"J Neurosci"},{"key":"B84","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s13311-018-0632-5","article-title":"Clinical trials in traumatic spinal cord injury","volume":"15","author":"Donovan","year":"2018","journal-title":"Neurotherapeutics"},{"key":"B85","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.3390\/ijms24043824","article-title":"Clinical trials targeting secondary damage after traumatic spinal cord injury","volume":"24","author":"Khaing","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41467-017-00926-5","article-title":"MHC matching improves engraftment of iPSC-derived neurons in non-human primates","volume":"8","author":"Morizane","year":"2017","journal-title":"Nat Commun"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e2401859","DOI":"10.1002\/advs.202401859","article-title":"On-chip neural induction boosts neural stem cell commitment: toward a pipeline for iPSC-based therapies","volume":"11","author":"Jain","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B88","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrc3034","article-title":"The tumorigenicity of human embryonic and induced pluripotent stem cells","volume":"11","author":"Ben-David","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e29597","DOI":"10.1371\/journal.pone.0029597","article-title":"Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons","volume":"7","author":"Falk","year":"2012","journal-title":"PLoS ONE"},{"key":"B90","doi-asserted-by":"publisher","first-page":"8322","DOI":"10.3390\/ijms22158322","article-title":"Efficient generation of neural stem cells from embryonic stem cells using a three-dimensional differentiation system","volume":"22","author":"Yoon","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B91","doi-asserted-by":"publisher","first-page":"14349","DOI":"10.3390\/ijms241814349","article-title":"Advancing spinal cord injury treatment through stem cell therapy: a comprehensive review of cell types, challenges, and emerging technologies in regenerative medicine","volume":"24","author":"Zeng","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40035-019-0180-x","article-title":"Replacing what's lost: a new era of stem cell therapy for Parkinson's disease","volume":"9","author":"Fan","year":"2020","journal-title":"Transl Neurodegener"},{"key":"B93","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13287-019-1163-7","article-title":"A scalable solution for isolating human multipotent clinical-grade neural stem cells from ES precursors","volume":"10","author":"Bohaciakova","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"B94","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1073\/pnas.0910012107","article-title":"Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency","volume":"107","author":"Hu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B95","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1479-5876-9-29","article-title":"Risk factors in the development of stem cell therapy","volume":"9","author":"Herberts","year":"2011","journal-title":"J Transl Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1186\/s13287-025-04826-0","article-title":"Addressing the challenges of immunogenicity, heterogeneity and tumorigenicity in the clinical translation of human embryonic stem cells","volume":"16","author":"Xia","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"B97","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1038\/s41467-021-23125-9","article-title":"Human stem cells harboring a suicide gene improve the safety and standardisation of neural transplants in Parkinsonian rats","volume":"12","author":"de Luzy","year":"2021","journal-title":"Nat Commun"},{"key":"B98","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41536-020-00100-4","article-title":"Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis","volume":"5","author":"Deinsberger","year":"2020","journal-title":"NPJ Regen Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nbt.1783","article-title":"A functionally characterized test set of human induced pluripotent stem cells","volume":"29","author":"Boulting","year":"2011","journal-title":"Nat Biotechnol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12943-023-01873-0","article-title":"Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol Cancer"},{"key":"B101","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.3390\/ijms25105177","article-title":"Possible strategies to reduce the tumorigenic risk of reprogrammed normal and cancer cells","volume":"25","author":"Lin","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B102","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat Biotechnol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1365-2990.1985.tb00007.x","article-title":"Neural tissue grafts and repair of the injured spinal cord","volume":"11","author":"Reier","year":"1985","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1006\/dbio.1995.1085","article-title":"Embryonic stem cells express neuronal properties in vitro","volume":"168","author":"Bain","year":"1995","journal-title":"Dev Biol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1006\/nbdi.1995.0004","article-title":"Neuroepithelial progenitor cells explanted from human fetal brain proliferate and differentiate in vitro","volume":"2","author":"Buc-Caron","year":"1995","journal-title":"Neurobiol Dis"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science (New York, N.Y.)"},{"key":"B107","doi-asserted-by":"publisher","first-page":"13726","DOI":"10.1073\/pnas.95.23.13726","article-title":"Derivation of pluripotent stem cells from cultured human primordial germ cells","volume":"95","author":"Shamblott","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B108","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.yexcr.2018.09.025","article-title":"Notch1 promotes mouse spinal neural stem and progenitor cells proliferation via p-p38-pax6 induced cyclin D1 activation","volume":"373","author":"Wang","year":"2018","journal-title":"Exp Cell Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1089\/scd.2012.0218","article-title":"The generation of definitive neural stem cells from PiggyBac transposon-induced pluripotent stem cells can be enhanced by induction of the NOTCH signaling pathway","volume":"22","author":"Salewski","year":"2013","journal-title":"Stem Cells Dev"},{"key":"B110","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13287-021-02452-0","article-title":"LINGO-1 regulates Wnt5a signaling during neural stem and progenitor cell differentiation by modulating miR-15b-3p levels","volume":"12","author":"Zhao","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16283","article-title":"microRNA-125b and its downstream Smurf1\/KLF2\/ATF2 axis as important promoters on neurological function recovery in rats with spinal cord injury","author":"Zhao","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S1995-7645(12)60133-3","article-title":"Establishment and expression of recombinant human glial cell line-derived neurotrophic factor and TNF \u03b1 receptor in human neural stem cells","volume":"5","author":"Zhuang","year":"2012","journal-title":"Asian Pac J Trop Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1016\/j.ymthe.2021.04.027","article-title":"Gsx1 promotes locomotor functional recovery after spinal cord injury","volume":"29","author":"Patel","year":"2021","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"B114","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41551-022-00868-4","article-title":"Production of human spinal-cord organoids recapitulating neural-tube morphogenesis","volume":"6","author":"Lee","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"B115","doi-asserted-by":"publisher","first-page":"2301787","DOI":"10.1002\/advs.202301787","article-title":"Symmetry breaking of human pluripotent stem cells (hPSCs) in micropattern generates a polarized spinal cord-like organoid (pSCO) with dorsoventral organization","volume":"10","author":"Seo","year":"2023","journal-title":"Adv Sci"},{"key":"B116","doi-asserted-by":"publisher","first-page":"123753","DOI":"10.1016\/j.biomaterials.2025.123753","article-title":"Generation of engineered human spinal cord organoid in channel-patterned collagen and transplantation for spinal cord regeneration","volume":"327","author":"Ma","year":"2025"},{"key":"B117","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.3390\/ijms25179592","article-title":"Innovative strategies in 3D bioprinting for spinal cord injury repair","volume":"25","author":"Kim","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1800261","DOI":"10.1002\/advs.201800261","article-title":"A modular assembly of spinal cord\u2013like tissue allows targeted tissue repair in the transected spinal cord","volume":"5","author":"Lai","year":"2018","journal-title":"Adv Sci"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e52787","DOI":"10.1371\/journal.pone.0052787","article-title":"Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity","volume":"7","author":"Kobayashi","year":"2012","journal-title":"PLoS ONE."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.stemcr.2015.11.013","article-title":"Grafted human iPS cell-derived oligodendrocyte precursor cells contribute to robust remyelination of demyelinated axons after spinal cord injury","volume":"6","author":"Kawabata","year":"2016","journal-title":"Stem Cell Rep"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.stemcr.2018.10.022","article-title":"Treatment with a gamma-secretase inhibitor promotes functional recovery in human iPSC-derived transplants for chronic spinal cord injury","volume":"11","author":"Okubo","year":"2018","journal-title":"Stem Cell Rep"},{"key":"B122","doi-asserted-by":"publisher","first-page":"743","DOI":"10.5966\/sctm.2014-0236","article-title":"Transplantation of induced pluripotent stem cell-derived neural stem cells mediates functional recovery following thoracic spinal cord injury through remyelination of axons","volume":"4","author":"Salewski","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.expneurol.2015.07.020","article-title":"Human iPS cell-derived astrocyte transplants preserve respiratory function after spinal cord injury","volume":"271","author":"Li","year":"2015","journal-title":"Exp Neurol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3727\/096368916X693671","article-title":"A comparative study of three different types of stem cells for treatment of rat spinal cord injury","volume":"26","author":"Ruzicka","year":"2017","journal-title":"Cell Transplant"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/jnr.22322","article-title":"Transplantation of galectin-1-expressing human neural stem cells into the injured spinal cord of adult common marmosets","volume":"88","author":"Yamane","year":"2010","journal-title":"J Neurosci Res"},{"key":"B126","doi-asserted-by":"publisher","first-page":"708","DOI":"10.5966\/sctm.2014-0215","article-title":"Allogeneic neural stem\/progenitor cells derived from embryonic stem cells promote functional recovery after transplantation into injured spinal cord of nonhuman primates","volume":"4","author":"Iwai","year":"2015","journal-title":"Stem Cells Transl Med"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1772547\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:36:36Z","timestamp":1779683796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1772547\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":126,"alternative-id":["10.3389\/fneur.2026.1772547"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1772547","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"article-number":"1772547"}}